Financial News

ChinaBio® Report: 2020 China Life Science Investment Hits New Records

In 2020, investment in China life science showed stellar growth. ChinaBio®'s survey  shows four of the five investment categories set new records, often doubling the year-earlier comparison, while the fifth, Mergers & Acquisitions, fell for the second year in a row:  VC/PE Fundraising: $56.1 billion; 2.3 times 2019; VC/PE Investments: $28.5 billion; 2.0 times 2019; IPOs: $23.3 billion; 2.9 times 2019; Partnering: $30.5 billion; 1.7 times 2019; Mergers and Acquisitions: $9.7 billion; a 60% drop from 2019. Between VC/PE investors and IPOs, there is a lot of capital available to young life science companies, which may explain why M&A underperformed so dramatically. With so much capital support readily available, owners of young life science companies have little reason to merge or sell their companies to competitors. More details....
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback